Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsShare-based CompensationShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

4D Molecular Therapeutics (FDMT) Gains from Investment Securities (2019 - 2025)

4D Molecular Therapeutics (FDMT) has disclosed Gains from Investment Securities for 7 consecutive years, with -$5.1 million as the latest value for Q4 2025.

  • Quarterly Gains from Investment Securities rose 14.5% to -$5.1 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$11.0 million through Dec 2025, down 74.08% year-over-year, with the annual reading at $2.4 million for FY2025, 74.34% down from the prior year.
  • Gains from Investment Securities for Q4 2025 was -$5.1 million at 4D Molecular Therapeutics, down from $1.4 million in the prior quarter.
  • The five-year high for Gains from Investment Securities was $8.8 million in Q3 2024, with the low at -$6.0 million in Q4 2024.
  • Average Gains from Investment Securities over 5 years is $1.0 million, with a median of $456250.0 recorded in 2021.
  • The sharpest move saw Gains from Investment Securities surged 92632.0% in 2022, then plummeted 598800.0% in 2024.
  • Over 5 years, Gains from Investment Securities stood at $478000.0 in 2021, then tumbled by 192.05% to -$440000.0 in 2022, then surged by 100.23% to $1000.0 in 2023, then tumbled by 598800.0% to -$6.0 million in 2024, then grew by 14.5% to -$5.1 million in 2025.
  • According to Business Quant data, Gains from Investment Securities over the past three periods came in at -$5.1 million, $1.4 million, and $1.6 million for Q4 2025, Q3 2025, and Q2 2025 respectively.